This trial will look at how progestin contraception affects menstrual patterns and the endometrium. Participants will receive contraceptive implant or injectable for 12 months & be asked to report bleeding patterns. 4 endometrial biopsies & blood draws, physical exams & pregnancy tests will be done. sCRNAseq will be used to profile the endometrium.
1 Primary · 0 Secondary · Reporting Duration: Baseline to 6 months
Awards & Highlights
2 Treatment Groups
1 of 2
1 of 2
52 Total Participants · 2 Treatment Groups
Primary Treatment: DMPA · No Placebo Group · Phase < 1
Who is running the clinical trial?
Age 18 - 40 · Female Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Does the selection criteria for this trial allow people aged 25 and over to participate?
"This study is actively searching for participants aged between 18 and 40 years old." - Anonymous Online Contributor
What are the qualifications to take part in this clinical exploration?
"This clinical trial is currently enrolling 52 individuals, who must be between 18 and 40 years old. Additionally, all participants should have reliable birth control methods in place." - Anonymous Online Contributor
Are there any open slots in this research endeavor for participants?
"The information available on clinicaltrials.gov reveals that this trial has concluded recruitment. It was initially made public in March 1st, 2023 and the most recent update came February 25th, 2023. Notwithstanding, there are still 53 other trials looking for participants at present time." - Anonymous Online Contributor